bioverse glp 1 reviews | Read Customer Service Reviews of gobioverse.com MicrosoftTeams-video
Description
Evidence-based comparison of retatrutide (GIP/GLP-1/glucagon triple agonist) and survodutide (GLP-1/glucagon dual agonist) for weight loss, MASH, and metabolic disease based on Phase 2 clinical trial data.
It is a newer drug on the market, and there is still some research being done on it, but the results so far have been very promising
Effective therapies, such as insulin and Glucagon-like peptide-1 (GLP-1), require injections, which are costly and result in less patient compliance
Beyond their role in energy homeostasis, gastrointestinal hormones have also been suggested to modulate the reward system
I thought this report was very helpful in showing the massive benefits GLP-1 medications and providing some metrics on side effects
